Ron C. Rietbroek

Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial

Annemieke Cats, Edwin P. M. Jansen, Nicole C.T. van Grieken et al. · The Lancet Oncology · 2018 · 562 citations

Surgical Oncology, Chemotherapy Versus Chemoradiotherapy, Gastrointestinal Oncology +8

<i>In vitro</i> formation of DNA adducts by cisplatin, lobaplatin and oxaliplatin in calf thymus DNA in solution and in cultured human cells

C.P. Saris, PJ.M. van de Vaart, Ron C. Rietbroek et al. · Carcinogenesis · 1996 · 157 citations · Full text

Cancer patients’ coping styles and doctor-patient communication

Lucille M.L. Ong, Mechteld R.M. Visser, F.J. van Zuuren et al. · Psycho-Oncology · 1999 · 125 citations

Quality Of Life, Family Medicine, Cancer Patients +17

Hyperthermia enhances the cytotoxicity and platinum-DNA adduct formation of lobaplatin and oxaliplatin in cultured SW 1573 cells

Ron C. Rietbroek, P. J. M. van de Vaart, J. Haveman et al. · Journal of Cancer Research and Clinical Oncology · 1997 · 100 citations · Full text

Chromatin, Platinum-dna Adduct Formation, Molecular Biology +6

Phase II trial of weekly locoregional hyperthermia and cisplatin in patients with a previously irradiated recurrent carcinoma of the uterine cervix

Ron C. Rietbroek, Marten S. Schilthuis, Piet Bakker et al. · Cancer · 1997 · 65 citations · Full text